Petousi N[au] - Search Results

Year	Number of Results
2003	1
2012	2
2013	2
2014	4
2015	1
2016	4
2017	4
2018	1
2019	4
2020	4
2021	5
2022	5
2023	4
2024	3

1

Editorial: Physiological phenotyping in respiratory diseases: New approaches.

King GG, Formenti F, Petousi N. King GG, et al. Among authors: petousi n. Front Physiol. 2023 Feb 9;14:1098839. doi: 10.3389/fphys.2023.1098839. eCollection 2023. Front Physiol. 2023. PMID: 36846324 Free PMC article. No abstract available.

2

A new piece in the puzzle: the eosinophil and the development of COPD.

Petousi N, Wooden A, Russell REK. Petousi N, et al. Eur Respir J. 2021 Oct 7;58(4):2101105. doi: 10.1183/13993003.01105-2021. Print 2021 Oct. Eur Respir J. 2021. PMID: 34620680 Free article. No abstract available.

3

Phenotyping of Severe Asthma in the Era of Broad-Acting Anti-Asthma Biologics.

Bourdin A, Brusselle G, Couillard S, Fajt ML, Heaney LG, Israel E, McDowell PJ, Menzies-Gow A, Martin N, Mitchell PD, Petousi N, Quirce S, Schleich F, Pavord ID. Bourdin A, et al. Among authors: petousi n. J Allergy Clin Immunol Pract. 2024 Apr;12(4):809-823. doi: 10.1016/j.jaip.2024.01.023. Epub 2024 Jan 25. J Allergy Clin Immunol Pract. 2024. PMID: 38280454 Free article. Review.

4

Ventilation-perfusion inequality in COVID-19 pneumonia.

Xu H, Petousi N, Robbins PA. Xu H, et al. Among authors: petousi n. J Appl Physiol (1985). 2021 Aug 1;131(2):868-869. doi: 10.1152/japplphysiol.00388.2021. J Appl Physiol (1985). 2021. PMID: 34397292 Free PMC article. No abstract available.

5

Identifying putative ventilation-perfusion distributions in COVID-19 pneumonia.

Xu H, Petousi N, Robbins PA. Xu H, et al. Among authors: petousi n. PLoS One. 2022 Aug 30;17(8):e0273214. doi: 10.1371/journal.pone.0273214. eCollection 2022. PLoS One. 2022. PMID: 36040974 Free PMC article.

6

Measuring lung function in airways diseases: current and emerging techniques.

Petousi N, Talbot NP, Pavord I, Robbins PA. Petousi N, et al. Thorax. 2019 Aug;74(8):797-805. doi: 10.1136/thoraxjnl-2018-212441. Epub 2019 Apr 29. Thorax. 2019. PMID: 31036773 Review.

7

The Lancet COPD Commission: broader questions remain.

Petousi N, Pavord ID, Couillard S. Petousi N, et al. Lancet. 2023 May 13;401(10388):1569-1570. doi: 10.1016/S0140-6736(23)00556-1. Lancet. 2023. PMID: 37179114 No abstract available.

8

Type-2 inflammation: a key treatable trait associated with lung function decline in chronic airways disease.

Petousi N, Pavord ID, Kent BD. Petousi N, et al. Thorax. 2024 Mar 15;79(4):291-292. doi: 10.1136/thorax-2023-221329. Thorax. 2024. PMID: 38373823 No abstract available.

9

Human adaptation to the hypoxia of high altitude: the Tibetan paradigm from the pregenomic to the postgenomic era.

Petousi N, Robbins PA. Petousi N, et al. J Appl Physiol (1985). 2014 Apr 1;116(7):875-84. doi: 10.1152/japplphysiol.00605.2013. Epub 2013 Nov 7. J Appl Physiol (1985). 2014. PMID: 24201705 Free PMC article. Review.

10

Toward a Predict and Prevent Approach in Obstructive Airway Diseases.

Couillard S, Petousi N, Smigiel KS, Molfino NA. Couillard S, et al. Among authors: petousi n. J Allergy Clin Immunol Pract. 2023 Mar;11(3):704-712. doi: 10.1016/j.jaip.2023.01.008. Epub 2023 Jan 20. J Allergy Clin Immunol Pract. 2023. PMID: 36682536

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

41 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year